COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,386 Articles (22,816 medRxiv, 8,570 bioRxiv)

Most recent first Previous |  Page 684: Articles 6831-6840  | Next

Safety and Immunogenicity of Intradermal Administration of Fractional Dose CoronaVac(R), ChAdOx1 nCoV-19 and BNT162b2 as Primary Series Vaccination
Chatsiricharoenkul, S., Niyomnaitham, S., Posen, H. J., Toh, Z. Q., Licciardi, P. V., Wongprompitak, P., Duangchinda, T., Pakchotanon, P., Chantima, W., Chokephaibulkit, K.
10.1101/2022.08.09.22278505 — Posted: 2022-08-10
Urine-based multi-omic comparative analysis of COVID-19 and bacterial sepsis-induced ARDS
Batra, R., Uni, R., Alvarez-Mulett, S., Gomez-Escobar, L. G., Patino, E., Hoffman, K., Simmons, W., Chetnik, K., Buyukozkan, M., Benedetti, E., Suhre, K., Schenck, E., Cho, S. J., Choi, A. M. K., Schmidt, F., Choi, M. E., Krumsiek, J.
10.1101/2022.08.10.22277939 — Posted: 2022-08-10
Early Detection of Emerging SARS-CoV-2 Variants of Interest for Experimental Evaluation
Wallace, Z. S., Davis, J., Niewiadomska, A. M., Olson, R. D., Shukla, M., Stevens, R., Zhang, Y., Zmasek, C. M., Scheuermann, R. H.
10.1101/2022.08.08.22278553 — Posted: 2022-08-10
Stability of SARS-CoV-2 in cold-chain transportation environments and the efficacy of disinfection measures
Peng, S., Li, G., Pathak, J. L., Guo, X., Lin, Y., Xu, H., Qiu, W., Zheng, J., Sun, W., Hu, X., Zhang, G., Li, B., Bi, X., Dai, J.
10.1101/2022.08.09.503429 — Posted: 2022-08-10
Function and Cryo-EM structures of broadly potent bispecific antibodies against multiple SARS-CoV-2 Omicron sublineages
Ren, P., Hu, Y., Peng, L., Yang, L., Suzuki, K., Fang, Z., Bai, M., Zhou, L., Feng, Y., Xiong, Y., Chen, S.
10.1101/2022.08.09.503414 — Posted: 2022-08-10
Computational pipeline provides mechanistic understanding of Omicron variant of concern neutralizing engineered ACE2 receptor traps
Remesh, S. G., Merz, G. E., Britol, A. F., Chio, U. S., Rizo, A. N., Pospiech, T. H., Lui, I., Laurie, M. T., Glasgow, J., Le, C. Q., Zhang, Y., Diwanji, D., Hernandez, E., Lopez, J., Pawar, K. I., Pourmal, S., Smith, A. M., Zhou, F., QBI Coronavirus Research Group Structural Biology Consortium, , DeRisi, J., Kortemme, T., Rosenberg, O. S., Glasgow, A., Leung, K. K., Wells, J. A., Verba, K. A.
10.1101/2022.08.09.503400 — Posted: 2022-08-10
Further humoral immunity evasion of emerging SARS-CoV-2 BA.4 and BA.5 subvariants
Jian, F., Yu, Y., Song, W., Yisimayi, A., Yu, L., Gao, Y., Zhang, N., Wang, Y., Shao, F., Hao, X., Xu, Y., Jin, R., Wang, Y., Xie, X. S., Cao, Y.
10.1101/2022.08.09.503384 — Posted: 2022-08-10
SARS-CoV-2 genomic diversity in households highlights the challenges of sequence-based transmission inference
Bendall, E., Paz-Bailey, G., Santiago, G. A., Porucznik, C. A., Stanford, J. B., Stockwell, M. S., Duque, J., Jeddy, Z., Veguilla, V., Major, C., Rivera-Amill, V., Rolfes, M. A., Dawood, F. S., Lauring, A. S.
10.1101/2022.08.09.22278452 — Posted: 2022-08-10
SARS-CoV-2 viral clearance and viral load kinetics in young children (1-6 years) compared to adults: Results of a longitudinal study in Germany
Sandoni, A. E., Schaffrath Rosario, A., Michel, J., Kuttig, T., Wurm, J., Damerow, S., Iwanowski, H., Finkel, B., Schrick, L., Buchholz, U., Haas, W., Varnaccia, G., Kubisch, U., Jordan, S., Schienkiewitz, A., Nitsche, A., Loss, J.
10.1101/2022.08.09.22278540 — Posted: 2022-08-10
Efficacy and safety of convalescent plasma to treat hospitalised COVID-19 patients with or without underlying immunodeficiency: a randomized clinical trial
Lacombe, K., Hueso, T., Porcher, R., Mekinian, A., Chiarabini, T., Georgin-Lavialle, S., Ader, F., Saison, J., Martin-Blondet, G., De Castro, N. A., Bonnet, F., Cazanave, C., Francois, A., Morel, P., Hermine, O., Pourcher, V., Michel, M., Lescure, X., Soussi, N., Brun, P., Pommeret, F., Sellier, P., Rousset, S., Piroth, L., Michot, J.-M., baron, g., de Lamballerie, X., Mariette, X., Tharaux, P.-L., Resche-Rigaux, M., Ravaud, P., Simon, T., Tiberghien, P.
10.1101/2022.08.09.22278329 — Posted: 2022-08-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).